investorscraft@gmail.com

Stock Analysis & ValuationPulse Biosciences, Inc. (PLSE)

Previous Close
$20.83
Sector Valuation Confidence Level
High
Valuation methodValue, $Upside, %
Artificial intelligence (AI)n/an/a
Intrinsic value (DCF)n/a
Graham-Dodd Methodn/a
Graham Formulan/a

Company Information

3957 Point Eden Way
Miami, CA 94545
United States
Phone: 510 906 4600
Industry: Medical - Instruments & Supplies
Sector: Healthcare
CEO: Paul Arthur LaViolette
Full Time Employees: 75

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. Pulse Biosciences, Inc. was incorporated in 2014 and is headquartered in Hayward, California.

HomeMenuAccount